Browse the evidence

Exposure to an unfavorable intrauterine or early postnatal environment (such as maternal obesity, diabetes, or undernutrition) programs permanent physiological changes in the offspring, significantly increasing the risk of developing obesity, insulin resistance, and metabolic syndrome in adulthood.

If your mother had obesity or diabetes during pregnancy, your body may be biologically predisposed to store fat and resist insulin. This is not your fault, but it is your responsibility to manage. Prioritize a healthy diet and regular physical activity from childhood to counteract this early-life programming, as your body may be more sensitive to high-calorie environments than others.

Accumulation of succinate and itaconate in classically activated macrophages stabilizes HIF-1alpha, which promotes further glycolysis and inflammation, creating a feedback loop.

Specific metabolites (succinate) can act as signaling molecules to lock immune cells into an inflammatory state by stabilizing key transcription factors.

Conjugated equine estrogens (CEE) are less effective than endogenous estradiol at inhibiting smooth muscle cell growth and preventing neointima formation due to lower binding affinity and potency at estrogen receptors.

Not all estrogens are equal. CEE, commonly used in HRT, contains weaker estrogens (estrone, estriol) that are less potent at blocking vascular remodeling than pure estradiol. This pharmacological difference may explain why CEE trials failed to show heart benefits while estradiol trials showed some vascular improvement.

In obese insulin-resistant individuals, elevated membrane-associated Protein Kinase C (PKC) isoforms (specifically PKC-epsilon and PKC-theta) phosphorylate the insulin receptor on serine/threonine residues, thereby reducing its tyrosine kinase activity and causing insulin resistance.

This research explains why obesity often leads to insulin resistance: excess fat leads to higher Free Fatty Acids, which activate PKC enzymes in muscle. These enzymes 'clog' the insulin receptor by adding phosphate groups to the wrong spots (serine/threonine), preventing it from working efficiently. While you cannot directly control PKC levels, reducing body fat and Free Fatty Acids through diet and exercise is the primary way to reduce this specific molecular blockage.

Existing anti-diabetic medications, including Metformin, GLP-1 agonists, and Verapamil, exert part of their therapeutic effect by downregulating TXNIP expression.

If you are taking Metformin or GLP-1 agonists (like Ozempic or Trulicity), one of the reasons they work is that they lower TXNIP levels in your body. This helps your cells use insulin better and protects your pancreas. This is a known mechanism, not a side effect.

Inhibition of the Insulin/IGF-1 signaling (IIS) pathway extends lifespan by promoting the nuclear translocation of the DAF-16/FOXO transcription factor, which then activates downstream genes for stress resistance and longevity.

This research highlights that the body's insulin signaling system acts as a master switch for longevity. In model organisms, reducing the activity of this pathway (mimicking dietary restriction or stress) activates a specific transcription factor (FOXO/DAF-16) that moves to the cell nucleus to turn on protective genes. While this is a mechanistic finding in worms and mice, it suggests that metabolic health and insulin sensitivity are biologically linked to the aging process.

Intermittent administration of rapamycin (e.g., 2 mg/kg every 5 days) extends lifespan in mice while minimizing metabolic and immunological side effects associated with chronic dosing.

For healthy adults seeking longevity interventions, intermittent dosing of rapamycin (specifically 2mg/kg every 5 days) appears to offer a superior risk-benefit profile compared to daily dosing. This schedule extends lifespan in mice and avoids the metabolic and immune suppression seen with chronic use. While human trials are ongoing, this protocol represents the current best evidence for mitigating rapamycin's known side effects while preserving its anti-aging benefits.

Rapamycin exhibits sexual dimorphism in efficacy, extending lifespan significantly more in female mice than in male mice.

If rapamycin is used for longevity, women may derive greater lifespan benefits than men, potentially due to differences in drug metabolism or baseline mTOR signaling. Men may require careful monitoring for side effects like insulin resistance.

Calorie restriction extends lifespan in yeast by acting as a mild biological stressor that activates the Sir2 deacetylase, rather than by simply slowing metabolism or reducing oxidative damage.

Calorie restriction extends lifespan in yeast by activating Sir2 through a mild stress response. This suggests that mild, intermittent reductions in caloric intake may trigger similar survival pathways in humans, potentially delaying age-related diseases.

Rapid weight gain in infancy, often driven by high protein intake in infant formula, is associated with an increased risk of later obesity and adverse metabolic outcomes.

If using infant formula, consider one with lower protein content, as it is associated with a lower risk of obesity at age 14-16 years. Breastfeeding is also protective. Monitor your infant's growth curve to ensure steady, not rapid, weight gain.

Homozygosity for the APOC3 -641C allele (rs2542052) is associated with lower serum APOC3 levels, favorable lipoprotein profiles, greater insulin sensitivity, lower hypertension prevalence, and significantly increased survival rates in Ashkenazi Jewish centenarians and their offspring.

This research highlights a specific genetic variant (APOC3 -641C) linked to better heart health and longer life in Ashkenazi Jewish populations. While you cannot change your DNA, this finding underscores the importance of maintaining healthy lipid levels, blood pressure, and insulin sensitivity, as these are the physiological pathways through which this genetic advantage operates. For those with this genotype, these health metrics may be even more critical to preserve.

Orexin deficiency is the primary cause of narcolepsy, characterized by a loss of orexin-containing neurons in the lateral hypothalamus.

For individuals with narcolepsy, the underlying cause is often the loss of orexin-producing neurons. Treatments may focus on managing symptoms or potentially replacing orexin signaling, as the system is crucial for maintaining wakefulness.

Exenatide treatment significantly reduces dopamine transporter (DAT) availability in the striatum, caudate, and putamen in patients with Alcohol Use Disorder.

Exenatide changes the brain's dopamine transporter levels in key reward areas, which may help compensate for the dopamine deficits seen in chronic alcohol use. This is a biological mechanism, not a direct measure of drinking behavior.

A high-fat, ketogenic diet causes severe hepatic insulin resistance in mice, driven by increased hepatic diacylglycerol (DAG) content and subsequent PKCε activation, despite preventing weight gain and increasing energy expenditure.

This study in mice shows that a very high-fat, near-zero carbohydrate diet can cause liver insulin resistance and fatty liver disease, even if it helps prevent weight gain. While popular for weight loss, this suggests potential risks for liver health that should be monitored, especially in individuals predisposed to metabolic issues.

Natural aging in mice correlates genome-wide with progeroid (accelerated) aging models, but not with long-lived models, indicating that natural aging resembles biological age markers of damage rather than longevity assurance.

Your body's gene expression as you age naturally looks more like accelerated aging (progeria) than like the healthy, long-lived state. This suggests that standard aging involves a 'survival' response to damage. Interventions that extend lifespan (like calorie restriction) may work by decoupling this survival response from the aging process.

Pharmacological activation of AMP-activated protein kinase (AMPK) via AICAR increases PGC-1α promoter activity and mRNA expression in skeletal muscle cells by enhancing the DNA binding of the transcription factor USF-1 to the EBox element of the PGC-1α promoter.

This research explains why endurance exercise and high-intensity efforts (which activate AMPK) are effective at improving mitochondrial health. The mechanism involves AMPK turning on the PGC-1α gene via specific DNA binding sites. To leverage this, engage in activities that create an energy deficit in muscle cells (like sustained aerobic exercise or high-intensity intervals), as this naturally activates the AMPK pathway described here.

Long-term administration of the GLP-1 receptor agonist exendin-4 (Ex4) promotes pancreatic beta-cell growth and survival, but this specific trophic effect is strictly dependent on Insulin Receptor Substrate 2 (Irs2) signaling; without Irs2, Ex4 cannot prevent beta-cell loss or diabetes progression.

This research clarifies that while GLP-1 drugs (like exendin-4/exenatide) effectively stimulate insulin release in the short term regardless of Irs2 status, their ability to actually grow or save beta cells long-term relies on a functional Irs2 signaling pathway. For patients with compromised Irs2 signaling, these drugs may improve blood sugar control via remaining beta cells but may not halt beta-cell loss or regenerate mass.

Tight glucose control (targeting 4.4-6.1 mmol/L) increases mortality in critically ill patients compared to a less strict target (less than 10 mmol/L), and optimal targets may vary based on diabetes status.

Do not use tight glucose control (targeting 4.4-6.1 mmol/L) in critically ill patients. Instead, aim for a less strict target (less than 10 mmol/L) to avoid the increased mortality risk associated with tight control. Consider individualizing targets based on diabetes status.

Inhibition of mTORC1 by rapamycin extends lifespan in multiple species by enhancing autophagy and mitophagy, thereby maintaining mitochondrial homeostasis.

Rapamycin extends lifespan in model organisms by boosting cellular cleanup (autophagy/mitophagy). While effective, chronic use has side effects. Dietary restriction also activates this pathway, offering a natural way to achieve similar benefits without pharmaceutical intervention.

Dietary fat intake does not activate brain PPARα to reverse hypophagia in mice with hypothalamic FAS inactivation, indicating that de novo synthesized fatty acids are required for this specific signaling pathway.

This study suggests that the brain's ability to regulate appetite via PPARα depends on fatty acids made internally by the enzyme FAS, not just those from your diet. This highlights the complexity of brain metabolism and why simply changing dietary fat might not fix all appetite regulation issues.

Leptin receptors are localized in specific regions of the human brain, including the hypothalamus, substantia nigra, and cerebellum, confirming the anatomical basis for leptin's role in central nervous system regulation.

This research confirms that leptin, a hormone produced by fat cells, communicates directly with your brain (specifically the hypothalamus) to help regulate energy balance and appetite. Understanding this link is crucial for grasping how body weight regulation works biologically.

Central nervous system (CNS) inflammation, specifically via IL-1β signaling, induces skeletal muscle atrophy through the activation of the hypothalamic-pituitary-adrenal (HPA) axis and subsequent glucocorticoid release, independent of direct peripheral cytokine action on muscle.

In chronic inflammatory conditions, muscle loss is driven significantly by the brain's response to inflammation (via the HPA axis and stress hormones), not just by the inflammation hitting the muscle directly. This suggests that interventions targeting the central inflammatory response or stress hormone pathways may be necessary to prevent muscle wasting, rather than just focusing on local muscle nutrition or exercise.

FOXO3a variants are associated with increased human life span, with the minor allele conferring a higher odds of longevity (OR 2.75) in centenarians of Japanese descent, and this association has been replicated in diverse populations including German, Italian, Chinese, and Danish cohorts.

FOXO3a is a gene linked to longevity, particularly in the insulin/IGF-1 signaling pathway. While you cannot change your genes, understanding this pathway highlights the importance of metabolic health. Interventions that modulate insulin sensitivity and cellular stress response (like exercise and balanced nutrition) may leverage this genetic potential.

In patients with ileum resected short bowel syndrome and a preserved colon, endogenous plasma concentrations of GLP-1 and GLP-2 are significantly elevated compared to healthy controls, contributing to functional intestinal adaptation.

For patients with extensive small bowel removal, keeping the colon is physiologically critical. The colon's L cells secrete high levels of GLP-1 and GLP-2 when nutrients reach them, which slows digestion and promotes intestinal growth. This natural hormonal response is a key reason why patients with a preserved colon have better outcomes than those without.